Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.

Arthritis and rheumatism - 1 Apr 2009

Akhmetshina Alfiya, Dees Clara, Busch Nicole, Beer Jürgen, Sarter Kerstin, Zwerina Jochen, Zimmer Andreas, Distler Oliver, Schett Georg, Distler Jörg H W

Abstract excerpt

OBJECTIVE: The cannabinoid receptor CB2 is predominantly expressed in non-neuronal tissue and exerts potent immunomodulatory effects. This study was undertaken to evaluate the role of CB2 in the pathogenesis of dermal fibrosis. METHODS: Mice deficient in CB2 (CB2(-/-) mice) and their wild-type li...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Bleomycin
Share to Bone Marrow Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dermis

Share to Leukocyte Count

Share to Receptor, Cannabinoid, CB2

Share to Scleroderma, Systemic

Share to Skin Diseases

Source

Identifiers

PMID: 19333940
DOI: 10.1002/art.24395

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19333940-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.PMID 19333940Read ↗

The CB2 receptor and its role as a regulator of inflammationSemantic proximity Read ↗

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseSemantic proximity Read ↗

Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency.Semantic proximity Read ↗

MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATIONSemantic proximity Read ↗

EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.Semantic proximity Read ↗

Expression and Functions of the CB2 Receptor in Human LeukocytesSemantic proximity Read ↗

Cannabinoid CB2R regulates T cell gut-homing in preclinical Crohns model.Semantic proximity Read ↗

To CB2 or Not CB2: Revisiting Renoprotection in AKI and CKDSemantic proximity Read ↗

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.Semantic proximity Read ↗

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.Semantic proximity Read ↗

Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.Semantic proximity Read ↗

The therapeutic potential of cannabinoids for integumentary wound management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.